The pharmaceutical industry says a popular class of targeted cancer therapies could one day replace chemotherapy and its potential for harsh side effects. Antibody-drug conjugates (ADCs) have taken major strides in recent years, as companies including AstraZeneca, Daiichi Sankyo, Pfizer and Merck are developing drugs in the space that could ease the trials of cancer treatment and make them big money in the process.
Healthcare costs are expected to rise in 2025 and older adults are increasingly looking to age in place — trends Samsung is targeting to get a bigger piece of the digital health market. And the company’s upcoming smartwatch update is another step in that direction, says Hon Pak, vice president and head of the digital health team for Samsung’s mobile business.
Managing the various symptoms and anxieties that often accompany cancer through music therapy, it turns out, is as effective as traditional cognitive behavioral therapy, according to a study presented at the American Society of Clinical Oncology meeting this month.
Stanford researchers have developed a breakthrough device called the milli-spinner thrombectomy, which uses compression and shear forces to safely shrink and remove blood clots, significantly improving first-attempt success rates in stroke and clot-related disease treatments.
According to a paper published just days before Apple's WWDC event, large reasoning models (LRMs) — like OpenAI o1 and o3, DeepSeek R1, Claude 3.7 Sonnet Thinking, and Google Gemini Flash Thinking — completely collapse when they're faced with increasingly complex problems. The paper comes from the same researchers who found other reasoning flaws in LLMs last year.